TNON logo

Tenon Medical, Inc. Stock Price

NasdaqCM:TNON Community·US$10.0m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

TNON Share Price Performance

US$1.16
-2.30 (-66.47%)
59.7% undervalued intrinsic discount
US$2.88
Fair Value
US$1.16
-2.30 (-66.47%)
57.8% undervalued intrinsic discount
US$2.75
Fair Value
Price US$1.16
AnalystConsensusTarget US$2.75

TNON Community Narratives

AnalystConsensusTarget·
Fair Value US$2.88 59.7% undervalued intrinsic discount

SiVantage Acquisition And Diversified Platforms Will Expand Market Reach

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
US$2.88
59.7% undervalued intrinsic discount
Revenue growth
100.15% p.a.
Profit Margin
12.49%
Future PE
12.11x
Share price in 2028
US$1.83

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
1 Reward

Tenon Medical, Inc. Key Details

US$2.9m

Revenue

US$1.6m

Cost of Revenue

US$1.3m

Gross Profit

US$14.0m

Other Expenses

-US$12.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 13, 2025
-1.47
45.44%
-429.45%
0%
View Full Analysis

About TNON

Founded
2012
Employees
27
CEO
Steven Foster
WebsiteView website
www.tenonmed.com

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Recent TNON News & Updates

Recent updates

No updates